注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
協和麒麟株式會社(原名:協和發酵麒麟株式會社)是一家主要從事醫藥生產和銷售業務的日本公司。該公司通過兩個業務部門運營。製藥部門從事藥品和其他產品的研究、開發、製造和銷售業務。生物化學品部門主要從事氨基酸和核酸相關物質以及保健產品的藥物和工業原料的研究、開發、製造和銷售業務。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Masashi Miyamoto | 62 | 2011 | President, CEO & Representative Director |
Akira Morita | - | 2019 | Outside Independent Chairman |
Tomomi Yatsu | 63 | 2021 | Outside Independent Auditor |
Takeyoshi Yamashita | - | 2021 | Chief Medical Officer, Senior Managing Executive Officer & Director |
Yuko Haga | 69 | 2019 | Independent Outside Director |
Yutaka Osawa | 65 | 2017 | CCO, Executive VP & Representative Director |
Hiroshi Komatsu | 62 | 2018 | Full-time Audit & Supervisory Board Member |
Rumiko Nakata | 68 | 2023 | Independent Outside Director |
Shinjiro Akieda | 59 | 2024 | Director |
Yoshihisa Q. Suzuki | 69 | 2022 | Independent Outside Director |
Takashi Oyamada | 69 | 2021 | Independent Outside Director |
Tomomi Yatsu | 64 | 2021 | Outside Audit & Supervisory Board Member |
Mayumi Tamura | 64 | 2022 | Outside Audit & Supervisory Board Member |
Toru Ishikura | 61 | 2023 | Audit & Supervisory Board Member |
Hajime Kobayashi | 59 | - | Outside Audit & Supervisory Board Member |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核